<VariationArchive VariationID="856637" VariationName="NM_020708.5(SLC12A5):c.266del (p.Lys89fs)" VariationType="Deletion" Accession="VCV000856637" Version="12" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-17" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="848433" VariationID="856637">
      <GeneList>
        <Gene Symbol="SLC12A5" FullName="solute carrier family 12 member 5" GeneID="57468" HGNC_ID="HGNC:13818" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="46021686" stop="46060150" display_start="46021686" display_stop="46060150" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="44650328" stop="44688788" display_start="44650328" display_stop="44688788" Strand="+" />
          </Location>
          <OMIM>606726</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020708.5(SLC12A5):c.266del (p.Lys89fs)</Name>
      <CanonicalSPDI>NC_000020.11:46035516:AAAAAA:AAAAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q13.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="46035517" stop="46035517" display_start="46035517" display_stop="46035517" variantLength="1" positionVCF="46035516" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="44664156" stop="44664156" display_start="44664156" display_stop="44664156" variantLength="1" positionVCF="44664155" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>K89fs</ProteinChange>
      <ProteinChange>K112fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.44664161del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.44664161del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.46035522del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.46035522del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046341.1" sequenceAccession="NG_046341" sequenceVersion="1" change="g.18833del">
            <Expression>NG_046341.1:g.18833del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001134771.2" sequenceAccession="NM_001134771" sequenceVersion="2" change="c.335del">
            <Expression>NM_001134771.2:c.335del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001128243.1" sequenceAccession="NP_001128243" sequenceVersion="1" change="p.Lys112fs">
            <Expression>NP_001128243.1:p.Lys112fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020708.5" sequenceAccession="NM_020708" sequenceVersion="5" change="c.266del" MANESelect="true">
            <Expression>NM_020708.5:c.266del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065759.1" sequenceAccession="NP_065759" sequenceVersion="1" change="p.Lys89fs">
            <Expression>NP_065759.1:p.Lys89fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2084489672" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020708.5(SLC12A5):c.266del (p.Lys89fs) AND Developmental and epileptic encephalopathy, 34" Accession="RCV001062140" Version="11">
        <ClassifiedConditionList TraitSetID="23289">
          <ClassifiedCondition DB="MedGen" ID="C4225257">Developmental and epileptic encephalopathy, 34</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-01-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-01-14" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26333769</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27436767</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="23289" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34424" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 34</ElementValue>
                <XRef ID="MONDO:0014718" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 34</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE34</ElementValue>
                <XRef Type="MIM" ID="616645" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SLC12A5-related epilepsy of infancy with migrating focal seizures (SLC12A5-EIMFS), reported to date in nine children, is characterized by onset of seizures before age six months and either developmental delay or developmental regression with seizure onset. Of these nine children, six had severe developmental delay with no progress of abilities and three made notable neurodevelopmental progress. Eight had postnatal microcephaly and hypotonia. In most children epilepsy begins as focal motor seizures (typically involving head and eye deviation) that become multifocal and intractable to conventional anti-seizure medication (ASM).</Attribute>
                <XRef ID="NBK537476" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16147" />
                <XRef ID="16147" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30763027</ID>
                <ID Source="BookShelf">NBK537476</ID>
              </Citation>
              <XRef ID="293181" DB="Orphanet" />
              <XRef ID="C4225257" DB="MedGen" />
              <XRef ID="MONDO:0014718" DB="MONDO" />
              <XRef Type="MIM" ID="616645" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3960884" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="b5738cb95feb60d98dac0699b785cdc6a7265ecdec4990387256ce7bdcc99dae|OMIM:616645" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002020630" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020708.4:c.266del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616645" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2392448" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="9098012|MedGen:C4225257" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001226920" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26333769</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27436767</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 856637). This variant has not been reported in the literature in individuals affected with SLC12A5-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys89Argfs*62) in the SLC12A5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC12A5 are known to be pathogenic (PMID: 26333769, 27436767).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.44664156del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225257" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3960884" TraitType="Disease" MappingType="XRef" MappingValue="616645" MappingRef="OMIM">
        <MedGen CUI="C4225257" Name="Developmental and epileptic encephalopathy, 34" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2392448" TraitType="Disease" MappingType="XRef" MappingValue="C4225257" MappingRef="MedGen">
        <MedGen CUI="C4225257" Name="Developmental and epileptic encephalopathy, 34" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

